Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion - PubMed (original) (raw)
doi: 10.1111/j.1365-2141.2008.07373.x. Epub 2008 Aug 24.
Andrea Rinaldi, Ivo Kwee, Elisa Sozzi, Donatella Raspadori, Paola M V Rancoita, Marta Scandurra, Davide Rossi, Clara Deambrogi, Daniela Capello, Emanuele Zucca, Daniela Marconi, Riccardo Bomben, Valter Gattei, Francesco Lauria, Gianluca Gaidano, Francesco Bertoni
Affiliations
- PMID: 18752589
- DOI: 10.1111/j.1365-2141.2008.07373.x
Free article
Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion
Francesco Forconi et al. Br J Haematol. 2008 Nov.
Free article
Abstract
Deletion of 17p (TP53) identifies a rare subset of chronic lymphocytic leukaemia (17p- CLL) with aggressive behaviour. Genome-wide DNA-profiling was performed to investigate 18 patients with 17p- CLL. All cases had multiple copy-number (CN) changes. Among the several recurrent CN changes identified, 8q24.13-q24.1-gain (MYC), 8p-loss (TNFRSF10A/B, also known as TRAIL1/2) and 2p16.1-p14-gain (REL/BCL11A) appeared frequently represented. 8p-loss and 2p16.1-p14-gain also appeared clinically relevant and predicted significant shorter time from diagnosis to treatment (8p-loss) and overall survival (8p-loss and 2p16.1-p14-gain, P < 0.05). These observations document a highly unstable genome in 17p- CLL and suggest that additional genes outside the TP53 locus may be important for tumour behaviour.
Similar articles
- Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
Fabris S, Mosca L, Todoerti K, Cutrona G, Lionetti M, Intini D, Matis S, Colombo M, Agnelli L, Gentile M, Spriano M, Callea V, Festini G, Molica S, Lambertenghi Deliliers G, Morabito F, Ferrarini M, Neri A. Fabris S, et al. Genes Chromosomes Cancer. 2008 Sep;47(9):781-93. doi: 10.1002/gcc.20579. Genes Chromosomes Cancer. 2008. PMID: 18521849 - Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.
Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB, Delabie J, Holte H. Stokke T, et al. Br J Cancer. 2001 Dec 14;85(12):1900-13. doi: 10.1054/bjoc.2001.2164. Br J Cancer. 2001. PMID: 11747333 Free PMC article. - Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S, López A, Rasillo A, Sayagués JM, Barrena S, Sánchez ML, Teodosio C, Giraldo P, Giralt M, Pérez MC, Romero M, Perdiguer L, Orfao A. Quijano S, et al. Cytometry B Clin Cytom. 2008 May;74(3):139-49. doi: 10.1002/cyto.b.20390. Cytometry B Clin Cytom. 2008. PMID: 18061951 - A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53.
Shindiapina P, Brown JR, Danilov AV. Shindiapina P, et al. Br J Haematol. 2014 Oct;167(2):149-61. doi: 10.1111/bjh.13042. Epub 2014 Jul 21. Br J Haematol. 2014. PMID: 25040077 Review. - Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation.
Buccheri V, Barreto WG, Fogliatto LM, Capra M, Marchiani M, Rocha V. Buccheri V, et al. Ann Hematol. 2018 Dec;97(12):2269-2278. doi: 10.1007/s00277-018-3503-6. Epub 2018 Oct 12. Ann Hematol. 2018. PMID: 30315344 Review.
Cited by
- Gain of the short arm of chromosome 2 (2p gain) has a significant role in drug-resistant chronic lymphocytic leukemia.
Kostopoulou F, Gabillaud C, Chapiro E, Grange B, Tran J, Bouzy S, Degaud M, Ghamlouch H, Le Garff-Tavernier M, Maloum K, Choquet S, Leblond V, Gabarre J, Lavaud A, Morel V, Roos-Weil D, Uzunov M, Guieze R, Bernard OA, Susin SA, Tournilhac O, Nguyen-Khac F; French Innovative Leukemia Organization (FILO) group. Kostopoulou F, et al. Cancer Med. 2019 Jun;8(6):3131-3141. doi: 10.1002/cam4.2123. Epub 2019 May 7. Cancer Med. 2019. PMID: 31066214 Free PMC article. - Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.
Burns A, Alsolami R, Becq J, Stamatopoulos B, Timbs A, Bruce D, Robbe P, Vavoulis D, Clifford R, Cabes M, Dreau H, Taylor J, Knight SJL, Mansson R, Bentley D, Beekman R, Martín-Subero JI, Campo E, Houlston RS, Ridout KE, Schuh A. Burns A, et al. Leukemia. 2018 Feb;32(2):332-342. doi: 10.1038/leu.2017.177. Epub 2017 Jun 6. Leukemia. 2018. PMID: 28584254 Free PMC article. - Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia.
Deambrogi C, De Paoli L, Fangazio M, Cresta S, Rasi S, Spina V, Gattei V, Gaidano G, Rossi D. Deambrogi C, et al. Am J Hematol. 2010 Jul;85(7):541-4. doi: 10.1002/ajh.21742. Am J Hematol. 2010. PMID: 20575024 Free PMC article. No abstract available. - Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogenetics.
Shao L, Kang SH, Li J, Hixson P, Taylor J, Yatsenko SA, Shaw CA, Milosavljevic A, Chang CC, Cheung SW, Patel A. Shao L, et al. J Mol Diagn. 2010 Sep;12(5):670-9. doi: 10.2353/jmoldx.2010.090192. Epub 2010 Aug 19. J Mol Diagn. 2010. PMID: 20724749 Free PMC article. - Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis.
Schultz RA, Delioukina M, Gaal K, Bedell V, Smith DD, Forman SJ, McDaniel LD, Ballif BC, Shaffer LG, Slovak ML. Schultz RA, et al. Mol Cytogenet. 2011 Feb 3;4(1):4. doi: 10.1186/1755-8166-4-4. Mol Cytogenet. 2011. PMID: 21291569 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous